1-11 of 11
Mustafa Khasraw
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice

Alex Broom, Leah Williams Veazey, Katherine Kenny, Imogen Harper, Michelle Peterie, Alexander Page, Nicole Cort, Jennifer Durling, Eric S. Lipp, Aaron C. Tan, Kyle M. Walsh, Brent A. Hanks, Margaret Johnson, Amanda E.D. Van Swearingen, Carey K. Anders, David M. Ashley, Mustafa Khasraw
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (9): 1670–1677.
https://doi.org/10.1158/1078-0432.CCR-23-0151
Published: 01 May 2023
View article titled, The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice
Open the PDF for The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice in another window
Journal Articles

Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas

Shiyou Wei, Delong Yin, Shengnan Yu, Xiang Lin, Milan R. Savani, Kuang Du, Yin Ku, Di Wu, Shasha Li, Hao Liu, Meng Tian, Yaohui Chen, Michelle Bowie, Seethalakshmi Hariharan, Matthew Waitkus, Stephen T. Keir, Eric T. Sugarman, Rebecca A. Deek, Marilyne Labrie, Mustafa Khasraw, Yiling Lu, Gordon B. Mills, Meenhard Herlyn, Kongming Wu, Lunxu Liu, Zhi Wei, Keith T. Flaherty, Kalil Abdullah, Gao Zhang, David M. Ashley
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (10): 2180–2195.
https://doi.org/10.1158/1078-0432.CCR-21-0833
Published: 13 May 2022
View article titled, Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas
Open the PDF for Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas in another window
Includes: Supplementary data
Journal Articles

Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma

Kirit Singh, Kristen A. Batich, Patrick Y. Wen, Aaron C. Tan, Stephen J. Bagley, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Susan M. Chang, Rifaquat Rahman, Evanthia Galanis, Alireza Mansouri, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John H. Sampson, John Simes, Donald A. Berry, Gelareh Zadeh, Tim F. Cloughesy, Minesh P. Mehta, Steven Piantadosi, Michael Weller, Amy B. Heimberger, Mustafa Khasraw
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 585–593.
https://doi.org/10.1158/1078-0432.CCR-21-2681
Published: 15 February 2022
View article titled, Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma
Open the PDF for Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma in another window
Journal Articles

Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement

Stephen J. Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Q. Lee, Gavin P. Dunn, Evanthia Galanis, Susan M. Chang, Louis Burt Nabors, Manmeet S. Ahluwalia, Roger Stupp, Minesh P. Mehta, David A. Reardon, Stuart A. Grossman, Erik P. Sulman, John H. Sampson, Simon Khagi, Michael Weller, Timothy F. Cloughesy, Patrick Y. Wen, Mustafa Khasraw
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 594–602.
https://doi.org/10.1158/1078-0432.CCR-21-2750
Published: 15 February 2022
View article titled, Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement
Open the PDF for Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement in another window
Journal Articles

Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage

James Isaacs, Aaron C. Tan, Brent A. Hanks, Xiaofei Wang, Kouros Owzar, James E. Herndon, II, Scott J. Antonia, Steven Piantadosi, Mustafa Khasraw
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (1): 13–22.
https://doi.org/10.1158/1078-0432.CCR-21-1593
Published: 05 January 2022
View article titled, Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage
Open the PDF for Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage in another window
Journal Articles

A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

Shengnan Yu, Shiyou Wei, Milan Savani, Xiang Lin, Kuang Du, Ilgen Mender, Silvia Siteni, Themistoklis Vasilopoulos, Zachary J. Reitman, Yin Ku, Di Wu, Hao Liu, Meng Tian, Yaohui Chen, Marilyne Labrie, Casey M. Charbonneau, Eric Sugarman, Michelle Bowie, Seethalakshmi Hariharan, Matthew Waitkus, Wen Jiang, Roger E. McLendon, Edward Pan, Mustafa Khasraw, Kyle M. Walsh, Yiling Lu, Meenhard Herlyn, Gordon Mills, Utz Herbig, Zhi Wei, Stephen T. Keir, Keith Flaherty, Lunxu Liu, Kongming Wu, Jerry W. Shay, Kalil Abdullah, Gao Zhang, David M. Ashley
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (24): 6800–6814.
https://doi.org/10.1158/1078-0432.CCR-21-0374
Published: 15 December 2021
View article titled, A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas
Open the PDF for A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas in another window
Includes: Supplementary data
Journal Articles

Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?

John H. Strickler, Brent A. Hanks, Mustafa Khasraw
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (5): 1236–1241.
https://doi.org/10.1158/1078-0432.CCR-20-3054
Published: 01 March 2021
View article titled, Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?
Open the PDF for Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better? in another window
Journal Articles

The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts

Alex Broom, Katherine Kenny, Alexander Page, Nicole Cort, Eric S. Lipp, Aaron C. Tan, David M. Ashley, Kyle M. Walsh, Mustafa Khasraw
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (22): 5809–5813.
https://doi.org/10.1158/1078-0432.CCR-20-2989
Published: 13 November 2020
View article titled, The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts
Open the PDF for The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts in another window
Journal Articles

PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?

Mustafa Khasraw, David A. Reardon, Michael Weller, John H. Sampson
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (20): 5287–5296.
https://doi.org/10.1158/1078-0432.CCR-20-1135
Published: 15 October 2020
View article titled, PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?
Open the PDF for PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma? in another window
Journal Articles

Adapting to a Pandemic — Conducting Oncology Trials during the SARS-CoV-2 Pandemic

Aaron C. Tan, David M. Ashley, Mustafa Khasraw
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13): 3100–3103.
https://doi.org/10.1158/1078-0432.CCR-20-1364
Published: 01 July 2020
View article titled, Adapting to a Pandemic — Conducting Oncology Trials during the SARS-CoV-2 Pandemic
Open the PDF for Adapting to a Pandemic — Conducting Oncology Trials during the SARS-CoV-2 Pandemic in another window
Journal Articles

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE

Brian M. Alexander, Sujuan Ba, Mitchel S. Berger, Donald A. Berry, Webster K. Cavenee, Susan M. Chang, Timothy F. Cloughesy, Tao Jiang, Mustafa Khasraw, Wenbin Li, Robert Mittman, George H. Poste, Patrick Y. Wen, W.K. Alfred Yung, Anna D. Barker
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (4): 737–743.
https://doi.org/10.1158/1078-0432.CCR-17-0764
Published: 14 February 2018
View article titled, Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
Open the PDF for Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE in another window